Reading PDEX? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track PDEX free→Reading PDEX? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track PDEX free→QuarterlyIQ Insights · PDEX
Price, valuation, and the composite score on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 5 valuation methods, at three horizons. Current price $62.32. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| Peer EV/EBITDA | 12M | $62.41 | 15.6 | 4.19 | TTM | high |
| Peer P/FCF | 12M | $61.17 | 29.3 | 2.09 | TTM | high |
| Peer P/E | 12M | $71.75 | 19.8 | 3.62 | TTM | high |
| Peer P/S | 12M | $59.99 | 2.7 | 21.82 | TTM | high |
| triangulated | 12M |
Monthly trailing P/E with quartile reference lines.
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Long-thesis check; widest uncertainty.
| $79.20 |
| 19.8 |
| 4.00 |
| Triangulated |
| high |
| Peer P/S | 3Y | $97.33 | 2.7 | 35.40 | Hist. CAGR(prov.) | medium |
| Peer P/S | 5Y | $134.38 | 2.7 | 48.88 | Hist. CAGR(prov.) | medium |